Scinai Immunotherapeutics Ltd.
SCNI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | – | $989 | $989 | $1,964 |
| Short-Term Investments | – | $0 | $0 | $0 |
| Receivables | – | $139 | $139 | $217 |
| Inventory | – | $0 | $0 | $0 |
| Other Curr. Assets | – | $378 | $378 | $210 |
| Total Curr. Assets | – | $1,506 | $1,506 | $2,391 |
| Property Plant & Equip (Net) | – | $10,334 | $10,334 | $11,057 |
| Goodwill | – | $0 | $0 | $0 |
| Intangibles | – | $0 | $0 | $0 |
| Long-Term Investments | – | $0 | $0 | $0 |
| Tax Assets | – | $0 | $0 | $0 |
| Other NC Assets | – | $0 | $0 | $0 |
| Total NC Assets | – | $10,334 | $10,334 | $11,057 |
| Other Assets | – | $0 | $0 | $0 |
| Total Assets | – | $11,840 | $11,840 | $13,448 |
| Liabilities | – | – | – | – |
| Payables | – | $659 | $659 | $376 |
| Short-Term Debt | – | $497 | $497 | $424 |
| Tax Payable | – | $0 | $0 | $0 |
| Deferred Revenue | – | $0 | $0 | $225 |
| Other Curr. Liab. | – | $964 | $964 | $781 |
| Total Curr. Liab. | – | $2,120 | $2,120 | $1,806 |
| LT Debt | – | $1,859 | $1,859 | $1,662 |
| Deferred Rev, NC | – | $0 | $0 | $0 |
| Deferred Tax Liab, NC | – | $0 | $0 | $0 |
| Other NC Liab. | – | $3 | $3 | $3 |
| Total NC Liab. | – | $1,862 | $1,862 | $1,665 |
| Other Liabilities | – | $0 | $0 | $0 |
| Cap. Leases | – | $2,063 | $2,063 | $1,826 |
| Total Liabilities | – | $3,982 | $3,982 | $3,471 |
| Equity | – | – | – | – |
| Pref Stock | – | $5,627 | $5,627 | $5,627 |
| Common Stock | – | $0 | $0 | $0 |
| Retained Earnings | – | -$121,673 | -$121,673 | -$117,539 |
| AOCI | – | -$1,740 | -$1,740 | -$1,740 |
| Other Equity | – | $125,644 | $125,644 | $123,629 |
| Total Equity | – | $7,858 | $7,858 | $9,977 |
| Supplemental Information | – | – | – | – |
| Minority Interest | – | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | – | $11,840 | $11,840 | $13,448 |
| Net Debt | $0 | $1,367 | $1,367 | $122 |